<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35338537</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-2254</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>The journal of gene medicine</Title>
          <ISOAbbreviation>J Gene Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Prenatal diagnosis of Walker-Warburg syndrome due to compound mutations in the B3GALNT2 gene.</ArticleTitle>
        <Pagination>
          <StartPage>e3417</StartPage>
          <MedlinePgn>e3417</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jgm.3417</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Congenital hydrocephalus is one of the symptoms of Walker-Warburg syndrome that is attributed to the disruptions of the genes, among which the B3GALNT2 gene is rarely reported. A diagnosis of the Walker-Warburg syndrome depends on the clinical manifestations and the whole-exome sequencing after birth, which is unfavorable for an early diagnosis.</AbstractText>
          <AbstractText Label="METHODS">Walker-Warburg Syndrome was suspected in two families with severe fetal congenital hydrocephalus. Whole-exome sequencing and Sanger sequencing were performed on the affected fetuses.</AbstractText>
          <AbstractText Label="RESULTS">The compound heterozygous variants c.1A&gt;G p.(Met1Val) and c.1151+1G&gt;A, and c.1068dupT p.(D357*) and c.1052 T&gt;A p.(L351*) in the B3GALNT2 gene were identified, which were predicted to be pathogenic and likely pathogenic, respectively. Walker-Warburg syndrome was prenatally diagnosed on the basis of fetal imaging and whole-exome sequencing.</AbstractText>
          <AbstractText Label="CONCLUSIONS">Our findings expand the spectrum of pathogenic mutations in Walker-Warburg syndrome and provide new insights into the prenatal diagnosis of the disease.</AbstractText>
          <CopyrightInformation>© 2022 The Authors. The Journal of Gene Medicine published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Peng</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Women's Hospital, School of Medicine Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jin</LastName>
            <ForeName>Pengzhen</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0001-5098-4050</Identifier>
            <AffiliationInfo>
              <Affiliation>Women's Hospital, School of Medicine Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Linyan</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Women's Hospital, School of Medicine Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Min</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Women's Hospital, School of Medicine Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Reproductive Genetics (Zhejiang University), Ministry of Education, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qian</LastName>
            <ForeName>Yeqing</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Women's Hospital, School of Medicine Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Reproductive Genetics (Zhejiang University), Ministry of Education, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeng</LastName>
            <ForeName>Wenshan</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Women's Hospital, School of Medicine Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Miaomiao</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Women's Hospital, School of Medicine Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Yuqing</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Women's Hospital, School of Medicine Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Yanfei</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Women's Hospital, School of Medicine Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dong</LastName>
            <ForeName>Minyue</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Women's Hospital, School of Medicine Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Reproductive Genetics (Zhejiang University), Ministry of Education, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Gene Med</MedlineTA>
        <NlmUniqueID>9815764</NlmUniqueID>
        <ISSNLinking>1099-498X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 2.4.1.-</RegistryNumber>
          <NameOfSubstance UI="C000594712">B3GALNT2 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.4.1.-</RegistryNumber>
          <NameOfSubstance UI="D017350">N-Acetylgalactosaminyltransferases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006849" MajorTopicYN="Y">Hydrocephalus</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017350" MajorTopicYN="Y">N-Acetylgalactosaminyltransferases</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011296" MajorTopicYN="N">Prenatal Diagnosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058494" MajorTopicYN="Y">Walker-Warburg Syndrome</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073359" MajorTopicYN="N">Whole Exome Sequencing</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">B3GALNT2</Keyword>
        <Keyword MajorTopicYN="Y">Walker-Warburg syndrome</Keyword>
        <Keyword MajorTopicYN="Y">congenital hydrocephalus</Keyword>
        <Keyword MajorTopicYN="Y">prenatal diagnosis</Keyword>
        <Keyword MajorTopicYN="Y">whole-exome sequencing</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>26</Day>
          <Hour>5</Hour>
          <Minute>33</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35338537</ArticleId>
        <ArticleId IdType="doi">10.1002/jgm.3417</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Furey CG, Choi J, Jin SC, et al. De Novo Mutation in Genes Regulating Neural Stem Cell Fate in Human Congenital Hydrocephalus. Neuron. 2018;99(2):302-314. doi:10.1016/j.neuron.2018.06.019</Citation>
        </Reference>
        <Reference>
          <Citation>Kolb DS. Klein C Congenital hydrocephalus in a Belgian draft horse associated with a nonsense mutation in B3GALNT2. Can Vet J. 2019;60(2):197-198.</Citation>
        </Reference>
        <Reference>
          <Citation>Ayala-Valdovinos MA, Galindo-García J, Sánchez-Chiprés D, Duifhuis-Rivera T. Genotyping of friesian horses to detect a hydrocephalus-associated c.1423C&gt;T mutation in B3GALNT2 using PCR-RFLP and PCR-PIRA methods: Frequency in stallion horses in México. Mol Cell Probes. 2017;32:69-71. doi:10.1016/j.mcp.2016.12.005</Citation>
        </Reference>
        <Reference>
          <Citation>Ross ME. Unlocking the genetic complexity of congenital hydrocephalus. Nat Med. 2020;26(11):1682-1683. doi:10.1038/s41591-020-1120-0</Citation>
        </Reference>
        <Reference>
          <Citation>Al DM, El-Hattab AW, Ismayl O, et al. B3GALNT2-Related Dystroglycanopathy: Expansion of the Phenotype with Novel Mutation Associated with Muscle-Eye-Brain Disease, Walker-Warburg Syndrome, Epileptic Encephalopathy-West Syndrome, and Sensorineural Hearing Loss. Neuropediatrics. 2018;49(4):289-295. doi:10.1055/s-0038-1651519</Citation>
        </Reference>
        <Reference>
          <Citation>Stevens E, Carss KJ, Cirak S, et al. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan. Am J Hum Genet. 2013;92(3):354-365. doi:10.1016/j.ajhg.2013.01.016</Citation>
        </Reference>
        <Reference>
          <Citation>Dobyns WB, Pagon RA, Armstrong D, et al. Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet. 1989;32(2):195-210. doi:10.1002/ajmg.1320320213</Citation>
        </Reference>
        <Reference>
          <Citation>Pabuşçu Y, Bulakbasi N, Kocaoğlu M, et al. Walker-Warburg syndrome variant. Comput Med Imaging Graph. 2002;26(6):453-458. doi:10.1016/s0895-6111(02)00026-5</Citation>
        </Reference>
        <Reference>
          <Citation>Warburg M. Heterogeneity of congenital retinal non-attachment, falciform folds and retinal dysplasia. A guide to genetic counselling. Hum Hered. 1976;26(2):137-148. doi:10.1159/000152795</Citation>
        </Reference>
        <Reference>
          <Citation>Cormand B, Pihko H, Bayés M, et al. Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease. Neurology. 2001;56(8):1059-1069. doi:10.1212/wnl.56.8.1059</Citation>
        </Reference>
        <Reference>
          <Citation>Walker AE. Lissencephaly. Arch Neurol Psych. 1942;48(1):13-29. doi:10.1001/archneurpsyc.1942.02290070023002</Citation>
        </Reference>
        <Reference>
          <Citation>Williams RS, Swisher CN, Jennings M, Ambler M, Caviness VS. Cerebro-ocular dysgenesis (Walker-Warburg syndrome): neuropathologic and etiologic analysis. Neurology. 1984;34(12):1531-1541. doi:10.1212/wnl.34.12.1531</Citation>
        </Reference>
        <Reference>
          <Citation>van Reeuwijk J, Brunner HG. van Bokhoven H Glyc-O-genetics of Walker-Warburg syndrome. Clin Genet. 2005;67(4):281-289. doi:10.1111/j.1399-0004.2004.00368.x</Citation>
        </Reference>
        <Reference>
          <Citation>Phillips JJ, Mahony BS, Siebert JR, Lalani T, Fligner CL, Kapur RP. Dandy-Walker malformation complex: correlation between ultrasonographic diagnosis and postmortem neuropathology. Obstet Gynecol. 2006;107(3):685-693. doi:10.1097/01.AOG.0000200594.85483.8a</Citation>
        </Reference>
        <Reference>
          <Citation>Stevens-Kroef M, Simons A, Rack K, Hastings RJ. Cytogenetic Nomenclature and Reporting. Methods Mol Biol. 2017;1541:303-309. doi:10.1007/978-1-4939-6703-2_24</Citation>
        </Reference>
        <Reference>
          <Citation>South ST, Lee C, Lamb AN, Higgins AW, Kearney HM, Working Group for the American College of Medical Genetics and Genomics Laboratory Quality Assurance Committee. ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013. Genet Med. 2013;15(11):901-909. doi:10.1038/gim.2013.129</Citation>
        </Reference>
        <Reference>
          <Citation>Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-424. doi:10.1038/gim.2015.30</Citation>
        </Reference>
        <Reference>
          <Citation>Shaheen R, Sebai MA, Patel N, et al. The genetic landscape of familial congenital hydrocephalus. Ann Neurol. 2017;81(6):890-897. doi:10.1002/ana.24964</Citation>
        </Reference>
        <Reference>
          <Citation>Jin SC, Dong W, Kundishora AJ, et al. Exome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus. Nat Med. 2020;26(11):1754-1765. doi:10.1038/s41591-020-1090-2</Citation>
        </Reference>
        <Reference>
          <Citation>McKnight I, Hart C, Park IH, Shim JW. Genes causing congenital hydrocephalus: Their chromosomal characteristics of telomere proximity and DNA compositions. Exp Neurol. 2021;335:113523-113542. doi:10.1016/j.expneurol.2020.113523</Citation>
        </Reference>
        <Reference>
          <Citation>Godfrey C, Clement E, Mein R, et al. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain. 2007;130(10):2725-2735. doi:10.1093/brain/awm212</Citation>
        </Reference>
        <Reference>
          <Citation>Sframeli M, Sarkozy A, Bertoli M, et al. Congenital muscular dystrophies in the UK population: Clinical and molecular spectrum of a large cohort diagnosed over a 12-year period. Neuromuscul Disord. 2017;27(9):793-803. doi:10.1016/j.nmd.2017.06.008</Citation>
        </Reference>
        <Reference>
          <Citation>Ho ML, Glenn OA, Sherr EH, Strober JB. Serial prenatal and postnatal MRI of dystroglycanopathy in a patient with familial B3GALNT2 mutation. Pediatr Radiol. 2017;47(7):884-888. doi:10.1007/s00247-017-3821-1</Citation>
        </Reference>
        <Reference>
          <Citation>Hedberg C, Oldfors A. Darin N B3GALNT2 is a gene associated with congenital muscular dystrophy with brain malformations. Eur J Hum Genet. 2014;22(5):707-710. doi:10.1038/ejhg.2013.223</Citation>
        </Reference>
        <Reference>
          <Citation>Hiruma T, Togayachi A, Okamura K, et al. A novel human beta1,3-N-acetylgalactosaminyltransferase that synthesizes a unique carbohydrate structure, GalNAcbeta1-3GlcNAc. J Biol Chem. 2004;279(14):14087-14095. doi:10.1074/jbc.M310614200</Citation>
        </Reference>
        <Reference>
          <Citation>Ducro BJ, Schurink A, Bastiaansen JW, et al. A nonsense mutation in B3GALNT2 is concordant with hydrocephalus in Friesian horses. BMC Genomics. 2015;16(1):761. doi:10.1186/s12864-015-1936-z-769.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
